Drug repurposing in pharmaceutical industry and its impact on market access: market access implications.

Drug repurposing is a group of development strategies employed in order to overcome some of the hurdles innate to drug research and development. Drug ...
162KB Sizes 0 Downloads 9 Views

Recommend Documents


Drug reformulations and repositioning in the pharmaceutical industry and their impact on market access: regulatory implications.
Repurposing has become a mainstream strategy in drug development, but it faces multiple challenges, amongst them the increasing and ever changing regulatory framework. This is the second study of a series of three-part publication project with the ul

Drug reformulations and repositioning in pharmaceutical industry and its impact on market access: reassessment of nomenclature.
Medicinal products that have been developed and approved for one disease may be the object of additional clinical development in other disease areas or of additional pharmaceutical development for new and different formulations. The newly developed p

New drug regulations in France: what are the impacts on market access? Part 2 - impacts on market access and impacts for the pharmaceutical industry.
Access to the French drug market is being impacted by an ongoing dramatic shift in practice as well as by two laws that came into force in December 2011. This new environment has been described and analyzed in two separate articles. This second artic

Pharmaceutical market access in emerging markets: concepts, components, and future.
This article intends to consolidate the concepts of pharmaceutical market access and highlight its growing importance in emerging markets. Market access has gained considerable attention worldwide as countries try to contain their escalating healthca

Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology Drugs.
Key Points - Representatives of the pharmaceutical industry call for a broader recognition of value within the assessment and appraisal of innovative drugs- Focus on value within the assessment and appraisal of drugs is jeopardized by financial drive

Pharmaceutical Industry in Vietnam: Sluggish Sector in a Growing Market.
Vietnam is a fast growing economy in the Asian region with a significantly high population (over 92 million in 2015). Although still expanding (about 1.1% on average during 2000-2015), the Vietnamese population is considered to be entering the ageing

Farm production, market access and dietary diversity in Malawi.
The association between farm production diversity and dietary diversity in rural smallholder households was recently analysed. Most existing studies build on household-level dietary diversity indicators calculated from 7d food consumption recalls. He

Market Access Advancements and Challenges in "Drug-Companion Diagnostic Test" Co-Development in Europe.
The pharma ecosphere is witnessing a measured transformation from the one-size-fits-all or blockbuster model of drugs to more informed and tailored personalized treatments that facilitate higher safety and efficacy for a relevant sub-population. Howe